(Q48950181)

17 February 2018

title

Comparison of intravenous and intra-arterial urokinase thrombolysis for acute ischaemic stroke. (English)

1 reference

17 February 2018

1 reference

Ducrocq X

1

1 reference

17 February 2018

Bracard S

2

1 reference

17 February 2018

Taillandier L

3

1 reference

17 February 2018

Anxionnat R

4

1 reference

17 February 2018

Lacour JC

5

1 reference

17 February 2018

Guillemin F

6

1 reference

17 February 2018

Debouverie M

7

1 reference

17 February 2018

Bollaert PE

8

1 reference

17 February 2018

publication date

1 January 2005

1 reference

17 February 2018

Journal of neuroradiology. Journal de neuroradiologie

published in

1 reference

17 February 2018

volume

32

1 reference

17 February 2018

issue

1

1 reference

17 February 2018

page(s)

26-32

1 reference

17 February 2018

Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0150-9861%2805%2983018-4

7 January 2021

The rtPA (alteplase) 0- to 6-hour acute stroke trial, part A (A0276g) : results of a double-blind, placebo-controlled, multicenter study. Thromblytic therapy in acute ischemic stroke study investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0150-9861%2805%2983018-4

7 January 2021

Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0150-9861%2805%2983018-4

7 January 2021

Local intra-arterial fibrinolytic therapy in acute carotid territory stroke. A pilot study.

1 reference

https://api.crossref.org/works/10.1016%2FS0150-9861%2805%2983018-4

7 January 2021

PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism.

1 reference

https://api.crossref.org/works/10.1016%2FS0150-9861%2805%2983018-4

7 January 2021

Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0150-9861%2805%2983018-4

7 January 2021

Streptokinase for acute ischemic stroke with relationship to time of administration: Australian Streptokinase (ASK) Trial Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0150-9861%2805%2983018-4

7 January 2021

Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism.

1 reference

https://api.crossref.org/works/10.1016%2FS0150-9861%2805%2983018-4

7 January 2021

Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)

1 reference

https://api.crossref.org/works/10.1016%2FS0150-9861%2805%2983018-4

7 January 2021

Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0150-9861%2805%2983018-4

7 January 2021

Early recanalisation in acute ischaemic stroke saves tissue at risk defined by MRI.

1 reference

https://api.crossref.org/works/10.1016%2FS0150-9861%2805%2983018-4

7 January 2021

Outcome and time course of recovery in stroke. Part I: Outcome. The Copenhagen Stroke Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0150-9861%2805%2983018-4

7 January 2021

Intracarotid urokinase with thromboembolic occlusion of the middle cerebral artery

1 reference

https://api.crossref.org/works/10.1016%2FS0150-9861%2805%2983018-4

7 January 2021

Thrombolytic therapy with streptokinase in acute ischemic stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS0150-9861%2805%2983018-4

7 January 2021

Predictors of clinical improvement, angiographic recanalization, and intracranial hemorrhage after intra-arterial thrombolysis for acute ischemic stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS0150-9861%2805%2983018-4

7 January 2021

Tissue plasminogen activator for acute ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0150-9861%2805%2983018-4

7 January 2021

Thrombolysis in acute ischemic stroke: does it work?

1 reference

https://api.crossref.org/works/10.1016%2FS0150-9861%2805%2983018-4

7 January 2021

Systematic review of evidence on thrombolytic therapy for acute ischaemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0150-9861%2805%2983018-4

7 January 2021

Local intra-arterial fibrinolytic therapy in patients with stroke: urokinase versus recombinant tissue plasminogen activator (r-TPA)

1 reference

https://api.crossref.org/works/10.1016%2FS0150-9861%2805%2983018-4

7 January 2021

10.1016/S0150-9861(05)83018-4

Identifiers

DOI

1 reference

17 February 2018

1 reference

17 February 2018